InvestorsObserver
×
News Home

Should Biotechnology Stock Imago Biosciences Inc (IMGO) Be in Your Portfolio Friday?

Friday, August 12, 2022 03:59 PM | InvestorsObserver Analysts

Mentioned in this article

Should Biotechnology Stock Imago Biosciences Inc (IMGO) Be in Your Portfolio Friday?

The 71 rating InvestorsObserver gives to Imago Biosciences Inc (IMGO) stock puts it near the top of the Biotechnology industry. In addition to scoring higher than 82 percent of stocks in the Biotechnology industry, IMGO’s 71 overall rating means the stock scores better than 71 percent of all stocks.

Overall Score - 71
IMGO has an Overall Score of 71. Find out what this means to you and get the rest of the rankings on IMGO!

What do These Ratings Mean?

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. InvestorsObserver makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts.
These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With Imago Biosciences Inc Stock Today?

Imago Biosciences Inc (IMGO) stock is trading at $18.20 as of 3:58 PM on Friday, Aug 12, a rise of $1.05, or 6.12% from the previous closing price of $17.15. The stock has traded between $17.19 and $18.26 so far today. Volume today is below average. So far 29,864 shares have traded compared to average volume of 105,744 shares. Click Here to get the full Stock Report for Imago Biosciences Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App